Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Photochemotherapy (Goeckerman and/or PUVA) for severe photoresponsive dermatoses requiring at least 4-8 hours of care under direct supervision of the physician (includes application of medication and dressings)

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Photochemotherapy, specifically techniques such as Goeckerman therapy and psoralen plus ultraviolet A (PUVA) therapy, is a specialized treatment approach utilized for managing severe photoresponsive dermatoses. These conditions include, but are not limited to, psoriasis, eczema, vitiligo, and mycosis fungoides, which are skin disorders that respond positively to light therapy. In PUVA therapy, the patient is administered psoralen, a medication that enhances the skin's sensitivity to UVA light, approximately two hours prior to exposure to the light source. This preparation is crucial as it maximizes the therapeutic effects of the subsequent light treatment. Goeckerman therapy, on the other hand, involves the application of coal tar to the affected skin areas, followed by exposure to UVA light. The entire procedure requires the patient to be under the direct supervision of a physician for a duration of 4 to 8 hours, ensuring that the treatment is administered safely and effectively. This supervision encompasses the time spent after the medication application and throughout the light therapy session. Additionally, post-treatment care may involve the physician applying dressings to the treated areas to promote healing and protect the skin.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure of photochemotherapy (CPT® Code 96913) is indicated for the treatment of severe photoresponsive dermatoses. These conditions are characterized by their responsiveness to light therapy and may include the following:

  • Psoriasis A chronic autoimmune condition that leads to the rapid growth of skin cells, resulting in scaling on the skin's surface.
  • Eczema A term for a group of conditions that cause the skin to become inflamed or irritated, often leading to itchy and red patches.
  • Vitiligo A skin disorder that causes patches of skin to lose their pigment, resulting in lighter areas on the skin.
  • Mycosis fungoides A type of skin lymphoma that presents with patches, plaques, or tumors on the skin.

2. Procedure

The procedure for photochemotherapy involves several critical steps to ensure effective treatment of the indicated dermatoses. Each step is designed to maximize the therapeutic benefits while ensuring patient safety.

  • Step 1: Medication Administration The process begins with the administration of psoralen, a medication that increases the skin's sensitivity to UVA light. This medication is typically given orally approximately two hours before the patient is exposed to UVA light. This timing is essential as it allows the psoralen to circulate in the bloodstream and adequately prepare the skin for the subsequent light therapy.
  • Step 2: Application of Coal Tar (Goeckerman Therapy) In cases where Goeckerman therapy is utilized, coal tar is applied to the affected areas of the skin. This application is intended to enhance the effectiveness of the light therapy by providing a protective barrier and additional therapeutic benefits to the skin.
  • Step 3: UVA Light Exposure Following the medication administration and, if applicable, the coal tar application, the patient is placed in a UVA light booth. The duration of exposure to the UVA light is determined based on the specific nature of the dermatosis being treated. The patient remains under direct supervision of the physician throughout this exposure to ensure safety and monitor for any adverse reactions.
  • Step 4: Post-Treatment Care After the light therapy session, the physician may apply dressings to the treated areas of the skin as needed. This step is crucial for protecting the skin and promoting healing, particularly in cases where the skin may be sensitive or irritated following treatment.

3. Post-Procedure

Post-procedure care following photochemotherapy is essential for optimal recovery and management of the treated skin areas. Patients are typically monitored for any immediate reactions to the treatment, and the physician may provide specific instructions regarding skin care. This may include recommendations for moisturizing the skin, avoiding sun exposure, and using gentle cleansers. The application of dressings, if performed, helps to protect the skin and can aid in the healing process. Patients may also be scheduled for follow-up appointments to assess the effectiveness of the treatment and make any necessary adjustments to their therapy regimen.

Short Descr PHOTOCHEMOTX SEV DERMATOSES
Medium Descr PHOTOCHEMOTHERAPY DERMATOSES 4-8 HRS SUPERVISION
Long Descr Photochemotherapy (Goeckerman and/or PUVA) for severe photoresponsive dermatoses requiring at least 4-8 hours of care under direct supervision of the physician (includes application of medication and dressings)
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 5 - Incident To Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Multiple Reduction Applies
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) P5A - Ambulatory procedures - skin
MUE 1
CCS Clinical Classification 174 - Other non-OR therapeutic procedures on skin and breast
Date
Action
Notes
2025-01-01 Changed Short Description changed.
2011-01-01 Changed Medium description changed. Short description changed.
2010-01-01 Changed Code description changed.
1991-01-01 Added First appearance in code book in 1991.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"